Centre of Postgraduate Medical Education
Quick facts
Marketed products
- Bupivacaine Spinal 0,5% Heavy - bolus · Anesthesiology
Bupivacaine blocks sodium channels in nerve fibers, preventing the initiation and propagation of action potentials to produce local anesthesia. - Bupivacaine Spinal 0,5% Heavy - titration · Anesthesia
Bupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.
Phase 3 pipeline
- Cholecalciferol 1200 · Nutritional/Metabolic
Cholecalciferol (vitamin D3) is converted in the body to its active form, calcitriol, which regulates calcium and phosphate homeostasis and modulates immune function.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Centre of Postgraduate Medical Education portfolio CI brief
- Centre of Postgraduate Medical Education pipeline updates RSS
Frequently asked questions about Centre of Postgraduate Medical Education
What are Centre of Postgraduate Medical Education's marketed drugs?
Top marketed products include Bupivacaine Spinal 0,5% Heavy - bolus, Bupivacaine Spinal 0,5% Heavy - titration.
What is Centre of Postgraduate Medical Education's pipeline?
Centre of Postgraduate Medical Education has 1 drugs in Phase 3, 1 in Phase 2, 2 in Phase 1. Late-stage candidates include Cholecalciferol 1200.
Related
- Bupivacaine Spinal 0,5% Heavy - bolus · Anesthesiology
- Bupivacaine Spinal 0,5% Heavy - titration · Anesthesia
- Sector hub: All tracked pharma companies